No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs573192640 |
chr3:46794436-46794437 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs184350789 |
chr3:46794441-46794442 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs561893627 |
chr3:46794480-46794481 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs189198259 |
chr3:46794483-46794484 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs72893366 |
chr3:46794496-46794497 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs563356779 |
chr3:46794552-46794553 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs530808323 |
chr3:46794624-46794625 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs181760188 |
chr3:46794628-46794629 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs573989212 |
chr3:46794629-46794630 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs59356397 |
chr3:46794643-46794644 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
11 |
rs144230911 |
chr3:46794645-46794646 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs546619674 |
chr3:46794668-46794669 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs377033303 |
chr3:46794712-46794713 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs57268847 |
chr3:46794745-46794746 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
15 |
rs148704364 |
chr3:46794798-46794799 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs533290091 |
chr3:46794808-46794809 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs569378156 |
chr3:46794815-46794816 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs545452856 |
chr3:46794871-46794872 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs540108576 |
chr3:46794880-46794881 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs186436598 |
chr3:46794887-46794888 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs143007122 |
chr3:46794898-46794899 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs572899834 |
chr3:46794899-46794900 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs563618430 |
chr3:46794910-46794911 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs533886819 |
chr3:46794925-46794926 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs188841376 |
chr3:46794958-46794959 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs542909653 |
chr3:46795034-46795035 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs554524956 |
chr3:46795035-46795036 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs61153905 |
chr3:46795062-46795063 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
29 |
rs544323992 |
chr3:46795063-46795064 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs34238793 |
chr3:46795078-46795079 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs35880732 |
chr3:46795084-46795085 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs56836203 |
chr3:46795085-46795086 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
33 |
rs181643407 |
chr3:46795150-46795151 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs113388975 |
chr3:46795180-46795181 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs546582866 |
chr3:46795194-46795195 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs376581103 |
chr3:46795236-46795237 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs374055116 |
chr3:46795237-46795238 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs528974901 |
chr3:46795301-46795302 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs375805203 |
chr3:46795304-46795305 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs550436922 |
chr3:46795326-46795327 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs377626764 |
chr3:46795339-46795340 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs151101330 |
chr3:46795340-46795341 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundance
|
43 |
rs551955013 |
chr3:46795341-46795342 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs566782866 |
chr3:46795564-46795565 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs534241062 |
chr3:46795631-46795632 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs35649252 |
chr3:46795651-46795652 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs186806769 |
chr3:46795657-46795658 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs538323586 |
chr3:46795710-46795711 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs556427741 |
chr3:46795716-46795717 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs34260667 |
chr3:46795720-46795721 |
Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|